JAMIE CASEY: Open Payments
NPI 1770020901 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 35 payments from 13 companies in 2025. Trend: 2023 $31 · 2024 $384 · 2025 $777
Food & beverage: $777
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $204 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $134 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Verona Pharma, Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $32 |
| Exact Sciences Corporation | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Viatris Specialty LLC | 1 | $24 |
| Boston Scientific Corporation | 1 | $22 |
Products named: Kerendia, LOKELMA, QULIPTA, TRELEGY ELLIPTA, UBRELVY, Ohtuvayre, Rybelsus, The Cologuard Plus Collection Kit.
Industry payments across AR — which companies pay providers there.
